The U.S. government collects taxes throughout the world and those taxes MUST be paid in US dollars. Most international trade eventually (if not exclusively) passes through the dollar system. Since no jurisdiction is entirely self-reliant, basically all aspects of the economic system touch on the dollar directly or indirectly. That tax collection is enforced by an apparatus with many levers of power including, but not limited to, the military and its nuclear weapons. So yes, the dollar is backed by the threat of nuclear annihilation in some sense.
Pasture land is not, usually, crop growing land. Moreover, the rain falls regardless. You could grow no crops, and your "water usage" would be exactly the same. Why would you count it?
But you have to feed the cells. And you can't just grow some plants and feed it to the cells, you have to manufacture a very precise blend of chemicals (amino acids, sugars, surfactants, antioxidants, etc.) at >99% purity for each one. Often extremely nasty solvents are involved in the production process. Usually, some sort of petroleum product is a feedstock. Those chemically synthesized materials are hardly green.
Yes there is an enormous difference in scale. Efficiency? In cell culture? In terms of GHG or emissions or energy use? I find that hard to believe. In my personal experience (not data, but relevant), none of the manufacturing scale processes were particularly optimized in terms of GHG/energy. Rather, yield was the primary target and consistency was the very close secondary target. Sometimes, vice versa. I 10x improvement of yield can very easily lead to higher GHG emission intensity, or no effect at all, e.g.
You should get your CO2 sensor checked, or move it to a place that is sampling outside air.
If you have only seen cherry-picked data and have not seen intelligent discussion (and such discussion is something you really want to have), then I suggest you read the IPCC reports and participate in discussions regarding the IPCC reports.
Your comment about the CO2 observation station on the active volcano is difficult to evaluate. I have never come across any convincing evidence that this matters. Have you?
Sure. But then you have to spend way more energy on the "filtering" part. It typically makes a lot more sense in terms of energy usage to just take tap water and run it through a polishing step (deionization and/or reverse osmosis), than to take the comparatively "dirty" water coming out of your process (dirty but not toxic) and try to clean that up.
It is of course impossible to verify either way, but I am very sure these statistics of 96% savings in freshwater are total nonsense. Anyone who has ever cultured cells on any scale can attest to the amount of water needed at any scale in terms of washing, rinsing, diluting, sterilizing, feeding, etc. Moreover, we have seen time and time again, the reporting of extremely high numbers for water usage in beef and milk production, but it turns out they are counting the water that falls as rain on the pasture land, or the rain/ground water used to grow the alfalfa. Should that be counted? Rain seems to be fairly renewable, but I admit that (in the extreme) society can harm ecosystems by diverting too much rain water (see Colorado River). Ground water renewability is a bit context dependent.
If the water savings is mostly nonsense, well then I also question the savings in GHG emissions. Land savings? Sure, fine, that makes sense... but farm land is orders of magnitude cheaper than land that has a fully functioning cell culture factory on it.
In the end, we will know if this works by what price it can sell at and make a marginal return. The jury is out on that one.
You don't need to do any of that. If you have enough neighbors who want to collude with you, you just take over the existing HOA and amend the rules (and/or take a lax enforcement attitude). The most benign way to do it is to make one tiny change to the HOA rules, an explicit provision that failure to enforce a known "violation" for more than 30 days renders the rule unenforceable forever more.
made with cells derived from cells extracted from an aborted fetus and then passaged (grow to several 100 cell divisions on a plate, suspend in solution, discard 99% of cells, repeat hundreds of times, eventually magic happens). To call the vaccine "made from aborted fetal cells" is their argument, but it elides an astounding amount of distance between the cells used for virus production and actual aborted fetal cells.
There is a reason, the U.S. has traditionally had a U.S. WHO representative in China since the first SARS outbreak, well until TRUMP. Trump's removal of the U.S. presence "on-the-ground" made it easy for the Chinese gov't to delay the real-time reporting while they struggled to figure out on their own whether they had something really serious to worry about or not. Covid-19 is not ENTIRELY Trump's fault, but he sure did just about everything he could to make it worse.
We did "waste" billions of dollars on a number of possible vaccine candidates that didn't actually pan out. See, Merck and Sanofi and GSK. Primate models are great (best we have), but we didn't "know" these things worked until end of December. It's beginning of Feb. I know the world is on fire, but things are moving fairly quickly. 1.34 million vaccinations a day in the U.S., from zero at beginning of Dec. That's pretty good. With much luck, the plateau in the vaccination rate this week gets resolved and we manage to hit 2M/day by end of Feb.
You are citing phase I data to support an implication that "clearly" phase 3 data was going to be positive. That is not how it works in real life. Many many many drug candidates look great after phase 1 and fail to become approved drugs.
Also, we did double our microfluidic device capacity. We more than doubled it. We increased our capacity by something like a million fold. Before these vaccines (first of their kind), there was no commercial scale capacity. This has all been invented in the last year. There was even a chance that achieving such capacity would not be possible. It is fairly common that drug candidates that look promising in phase 1 or 2 simply cannot be manufactured at scale with the quality required to ensure consistent safety and efficacy.
I can assure you, under most meanings of the words "uncommon" and "common", microfluidic devices for manufacturing these nanoscale encapsulated mRNAs are definitely "uncommon." In fact, I would wager that there are probably a handful in the world at most. Moreover, it's a fair bet that no two are alike.
Additionally, until this brand new mRNA vaccine technology actually demonstrated efficacy it was not quite so clear cut that we should put a huge proportion of our resources into making more of these devices, rather than explore different vaccine platforms.
You are papering over the fact that even cash accounts require Robinhood to have sufficient cash to cover amounts liable until the trade is actually settled. There is an entire web of relationships between DTCC, robinhood, bank LOCs, etc. that make robinhood's capital requirements explode when GME stock explodes 1000% up and becomes the most traded share in the entire universe of stocks.
??? I think that is highly dependent on housing costs and how early you retire. If you have kids who are not in college (and live where college is not free) and have not paid off your house, 1MM in retirement is a woefully small amount of money (I think?). At 5% withdrawal (risky), you are living on 50K a year, 30K post-tax. That's not even going to cover your mortgage in many cases, much less other living costs.
Your proposal is highly unspecified. I suggest that you should add a durability term or the 50% effectiveness is meaningless. That is, for how long do you suspect there to be at least 50% effectiveness?
The OP's categorical statement on partial immunity is entirely false. Look at the Astrazeneca data in the Lancet. No hospitalizations in the treatment arm. That is evidence of "partial immunity."
It is not about who has "balls." You seem to think this is just a balancing of risks. It is not. It is a balancing of "what do we actually have data to support" versus "what do we hope to be the case but have no actual evidence to suggest it is so."
It reads to me like a letter by someone who invests in target date retirement funds and index etfs by dollar cost averaging on an automated schedule, and avoids investing in tulip bulbs, because the available data shows that this is the most prudent approach.
In this thread, none of the comments seem to note a key issue here as stated in the FDA post: "Those participants who did not receive two vaccine doses at either a three-or four-week interval were generally only followed for a short period of time, such that we cannot conclude anything definitive about the depth or duration of protection after a single dose of vaccine from the single dose percentages reported by the companies. "
In other words, we basically have NO DATA on single dose schedules for Moderna/Pfizer vaccines. There's too few of them anyway to gain any statistically meaningful insight even if we did follow up on these study participant washouts. This is hydroxychloroquine all over again. When you are looking at inadequate data, you can find all sorts of patterns. It is very rare that such patterns turn out to be real. The most reasonable approach is to assume that there is little to no durable protection from a single dose, just like most prime/boost vaccines.
The standard of care has evolved based on the data. Unlike other respiratory infections, intubation often provides no benefits and some harm to those COVID patients who are not literally dying of asphyxiation (critically low O2 saturation). Basically intubation is now a last-ditch effort, that can and does save lives. But you'd better hope you don't need it because the likelihood of needing intubation AND surviving it are low.
I think you misunderstand the clinical trial approval process. Yes, phase 2 is primarily about safety, but these are much smaller trials than phase 3, which in turn is much smaller than the post-marketing patient population (cohort). Safety issues routinely arise in phase 3, or even after, due to the much larger cohort sizes. Good phase 2 results are not proof of safety, rather an indication of safety. It is bordering on genocidal levels of reckless endangerment to release a vaccine for general use after Phase 2 in the hopes that it might be effective and is probably safe.
Do you think there were a bunch of experimental vaccines just floating around on the . . . dark web? ... That's not how it works. The vaccine makers themselves have no interest in distributing unproven vaccines. I myself was highly confident (and posted such on HN) that we would have a successful coronavirus vaccine, based on the scientific information available early in the pandemic. But it wasn't a surety. You must have a randomized trial or you risk very very bad outcomes. Some experimental vaccines (e.g., dengue) actually make the viral infection worse. Some don't work at all (e.g., Sanofi's covid vaccine). Heck Sanofi's vaccine is likely the easiest to manufacture and distribute. If we followed your "plan", it would likely be that most got the ineffective Sanofi vaccine and we would be moving dead bodies around with bull dozers as "vaccinated" people failed to practice social distancing.